Goldman Sachs’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-12,800
Closed -$181K – 6574
2026
Q1
$181K Buy
+12,800
New +$189K ﹤0.01% 6110
2023
Q4
– Sell
-49,190
Closed -$713K – 5622
2023
Q3
$713K Buy
+49,190
New +$736K ﹤0.01% 4468

Other funds holding BCAT

Goldman Sachs's BCAT Position: Q2 2026 in Review

Goldman Sachs sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q2 2026, closing a stake of 12,800 shares — an estimated $181K sold.

Goldman Sachs first reported a position in BCAT in Q3 2023 and held it in 2 quarters. The position peaked at $713K in Q3 2023. 110 funds tracked by Wall St. Rank hold BCAT as of Q2 2026.

  • Goldman Sachs reported no remaining BlackRock Capital Allocation Term Trust position as of Q2 2026 after selling out during the quarter.
  • Goldman Sachs sold 12,800 BlackRock Capital Allocation Term Trust shares in Q2 2026, an estimated $181K.
  • Goldman Sachs first reported a position in BlackRock Capital Allocation Term Trust in Q3 2023 and held it in 2 quarters.
  • Goldman Sachs's BlackRock Capital Allocation Term Trust position peaked at $713K in Q3 2023.
  • 110 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.